HomeSearchClinical Cancer Bulletin

Clinical Cancer Bulletin

Springer Nature · Singapore

eISSN2791-3937
DOAJOpen Access
52
/ 100
Established
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
DOAJ-listed52
Total52
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
96
days submission → published
measured · last 20 articles · accept 74d

Aims & Scope✦ Inferred from recent articles

This journal focuses on advancements in cancer treatment and diagnosis, with a particular emphasis on immunotherapies like CAR-T cell therapy and tumor-infiltrating lymphocyte therapy, as well as AI-driven drug design and diagnostic techniques such as ultrasound-guided biopsies and liquid biopsies. The scope also includes research on specific cancers like lung, liver, and colorectal cancer, and the management of treatment-related adverse events.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionSingapore
Primary LanguageEnglish
1st Year Published
StatusActive
Total Publications
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer ReviewAnonymous peer review
Review Time
Acceptance Rate
OA LicenseCC BY
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

8/12 · 67%
Do you know the journal / publisher?
Springer Nature
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2791-3937
Indexed in a trusted database?
DOAJ
Peer review process documented?
Anonymous peer review
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsFerroptosis and cancer prognosisCAR-T cell therapy researchLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune ResponsesRNA modifications and cancerCancer-related molecular mechanisms research

Frequently asked questions about Clinical Cancer Bulletin

Is Clinical Cancer Bulletin a predatory journal?

PubScope has no integrity flags on record for Clinical Cancer Bulletin: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Clinical Cancer Bulletin?

Clinical Cancer Bulletin is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.

Is Clinical Cancer Bulletin indexed in Scopus and Web of Science?

Clinical Cancer Bulletin is indexed in DOAJ.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref